Abeona Therapeutics Targets RDEB Market With Promising Pz-cel Therapy

Abeona Therapeutics Inc. (NASDAQ: ABEO ) develops gene and cell therapies for serious genetic disorders. ABEO's AIM platform uses adeno-associated virus (AAV) vectors for targeted delivery of genetic material that correct functions across multiple body organs. This is how ABEO's My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, U ...